Search Results - "Dupas, J.‐L."

Innate mucosal‐associated invariant T (MAIT) cells are activated in inflammatory bowel diseases by Serriari, N.‐E., Eoche, M., Lamotte, L., Lion, J., Fumery, M., Marcelo, P., Chatelain, D., Barre, A., Nguyen‐Khac, E., Lantz, O., Dupas, J.‐L., Treiner, E.

“…Summary Inflammatory bowel diseases are characterized by a deregulated immune response targeting the gut bacterial flora. Mucosal‐associated invariant T (MAIT)…”
Get full text

The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10‐ to 19‐year‐old age bracket (1988–2007) by Chouraki, V., Savoye, G., Dauchet, L., Vernier‐Massouille, G., Dupas, J.‐L., Merle, V., Laberenne, J.‐E., Salomez, J.‐L., Lerebours, E., Turck, D., Cortot, A., Gower‐Rousseau, C., Colombel, J.‐F.

“…Aliment Pharmacol Ther 2011; 33: 1133–1142 Summary Background  Crohn’s disease incidence rates have stabilised in industrialised countries since the 1980s…”
Get full text

Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non‐invasive laboratory tests by NGUYEN‐KHAC, E., CHATELAIN, D., TRAMIER, B., DECROMBECQUE, C., ROBERT, B., JOLY, J.‐P., BREVET, M., GRIGNON, P., LION, S., LE PAGE, L., DUPAS, J.‐L.

“…Summary Background  Systematic screening for liver fibrosis in heavy‐drinking patients is a challenge. Aims  To assess Fibroscan for non‐invasive diagnosis of…”
Get full text

Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis by Marie, I., Antonietti, M., Houivet, E., Hachulla, E., Maunoury, V., Bienvenu, B., Viennot, S., Smail, A., Duhaut, P., Dupas, J ‐L., Dominique, S., Hatron, P.‐Y., Levesque, H., Benichou, J., Ducrotté, P.

“…Summary Background To date, there are no large studies on videocapsule endoscopy in systemic sclerosis (SSc). Consequently, the prevalence and features of…”
Get full text

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study by Baron, S, Turck, D, Leplat, C, Merle, V, Gower-Rousseau, C, Marti, R, Yzet, T, Lerebours, E, Dupas, J-L, Debeugny, S, Salomez, J-L, Cortot, A, Colombel, J-F

“…Background: Environmental exposures in early life have been implicated in the aetiology of inflammatory bowel disease. Objective: To examine environmental risk…”
Get full text

Chemistry of free radicals produced by oxidation of endogenous α-aminoketones. A study of 5-aminolevulinic acid and α-aminoacetone by fast kinetics spectroscopy by Morlière, P., Hug, G.L., Patterson, L.K., Mazière, J.-C., Ausseil, J., Dupas, J.-L., Ducroix, J.-P., Santus, R., Filipe, P.

“…Excess 5-aminolevulinic acid (ALA) and α-aminoacetone (AA) are implicated in ketosis, porphyrinpathies and diabetes. Pathologic manifestations involve O2−,…”
Get full text

Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999) by Molinié, F, Gower-Rousseau, C, Yzet, T, Merle, V, Grandbastien, B, Marti, R, Lerebours, E, Dupas, J-L, Colombel, J-F, Salomez, J-L, Cortot, A

“…Background: Northern France was characterised by a high incidence of Crohn’s disease (CD) and a low incidence of ulcerative colitis (UC) according to the first…”
Get full text

On the repair of oxidative damage to apoferritin: a model study with the flavonoids quercetin and rutin in aerated and deaerated solutions by Morlière, P, Mazière, J-C, Patterson, L K, Conte, M-A, Dupas, J-L, Ducroix, J-P, Filipe, P, Santus, R

“…Ferritin (Ft) impairment through (•)O2(-), H2O2, and (•)OH production occurs in the cases of ketoses, diabetes mellitus, acute intermittent porphyria and…”
Get more information

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study by Gornet, J.‐M., Couve, S., Hassani, Z., Delchier, J.‐C., Marteau, P., Cosnes, J., Bouhnik, Y., Dupas, J.‐L., Modigliani, R., Taillard, F., Lemann, M.

“…Summary Background : The efficacy of infliximab in ulcerative colitis (UC) and indeterminate colitis has been poorly assessed and preliminary results are…”
Get full text

Gastrointestinal: Ano-popliteal fistula in Crohn's disease by Deschepper, C, Chivot, C, Gaffez, M, Yzet, T, Dupas, JL, Fumery, M

Get full text

Mapping of a susceptibility locus for Crohn's disease on chromosome 16 by Hugot, Jean-Pierre, Laurent-Puig, Pierre, Gower-Rousseau, Corine, Olson, Jane M, Lee, John C, Beaugerie, Laurent, Naom, Isam, Dupas, Jean-Louis, Van Gossum, André, Orholm, Marianne, Bonaiti-Pellie, Catherine, Weissenbach, Jean, Mathew, Christopher G, Lennard-Jones, John E, Cortot, Antoine, Colombel, Jean-Frédéric, Thomas, Gilles

“…Crohn's disease (CD) and ulcerative colitis are the major forms of chronic inflammatory bowel diseases in the western world, and occur in young adults with an…”
Get full text

Incidence of inflammatory bowel disease in northern France (1988-1990) by Gower-Rousseau, C, Salomez, J L, Dupas, J L, Marti, R, Nuttens, M C, Votte, A, Lemahieu, M, Lemaire, B, Colombel, J F, Cortot, A

“…There were no data concerning the incidence of inflammatory bowel disease (IBD) in France. The aim of this study was to investigate the incidence of Crohn's…”
Get full text

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients by Ruszniewski, P, Ducreux, M, Chayvialle, J A, Blumberg, J, Cloarec, D, Michel, H, Raymond, J M, Dupas, J L, Gouerou, H, Jian, R, Genestin, E, Bernades, P, Rougier, P

“…BACKGROUND: Somatostatin analogues effectively control flushing and diarrhoea in patients with the carcinoid syndrome. The octapeptide lanreotide is available…”
Get full text

Clinical characteristics of Crohn's disease in 72 families by Colombel, JF, Grandbastien, B, Gower-Rousseau, C, Plegat, S, Evrard, JP, Dupas, JL, Gendre, JP, Modigliani, R, Belaiche, J, Hostein, J, Hugot, JP, van Kruiningen, H, Cortot, A

“…BACKGROUND & AIMS: Familial aggregation argues for genetic susceptibility to Crohn's disease. The aim of this study was to compare the age of onset and the…”
Get full text

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride by Abitbol, V., Mary, J. Y., Roux, C., Soulé, J. C., Belaiche, J., Dupas, J. ‐L., Gendre, J. P., Lerebours, E., Chaussade, S.

“…Background: Previous data have indicated low bone formation as a mechanism of osteoporosis in inflammatory bowel disease. Fluoride can stimulate bone…”
Get full text

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study by Mahmud, N, Kamm, M A, Dupas, J L, Jewell, D P, O'Morain, C A, Weir, D G, Kelleher, D

“…BACKGROUND AND AIMS The benefit of 5-aminosalicylic acid therapy for maintenance of remission in Crohn's disease is controversial. The primary aim of this…”
Get full text

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial by Marteau, P, Lémann, M, Seksik, P, Laharie, D, Colombel, J F, Bouhnik, Y, Cadiot, G, Soulé, J C, Bourreille, A, Metman, E, Lerebours, E, Carbonnel, F, Dupas, J L, Veyrac, M, Coffin, B, Moreau, J, Abitbol, V, Blum-Sperisen, S, Mary, J Y

“…Background and aims: Early endoscopic recurrence is frequent after intestinal resection for Crohn’s disease. Bacteria are involved, and probiotics may modulate…”
Get full text

Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis by Leblanc, S, Allez, M, Seksik, P, Flourié, B, Peeters, H, Dupas, J L, Bouguen, G, Peyrin-Biroulet, L, Duclos, B, Bourreille, A, Dewit, O, Bouhnik, Y, Michetti, P, Chaussade, S, Saussure, P, Mary, J Y, Colombel, J F, Lémann, M

“…Rescue therapy with either cyclosporine (CYS) or infliximab (IFX) is an effective option in patients with intravenous steroid-refractory attacks of ulcerative…”
Get full text

Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas by Czernichow, P, Hochain, P, Nousbaum, J B, Raymond, J M, Rudelli, A, Dupas, J L, Amouretti, M, Gouérou, H, Capron, M H, Herman, H, Colin, R

“…To compare incidence rates and epidemiological characteristics of acute upper gastrointestinal haemorrhage (AUGIH) in France with those of other European…”
Get more information

Surgical conservative treatment of recurrent bleeding duodenal ulcer by Brehant, O, Duval, H, Dumont, F, Fuks, D, Deshpande, S, Verhaeghe, P, Yzet, T, Bartoli, E, Brazier, F, Mauvais, F, Lobjoie, E, Dupas, J L, Regimbeau, J M

“…Endoscopic hemostasis and proton pump inhibitors (PPI) have decreased the incidence of rebleeding and reduced the need for surgery for bleeding duodenal ulcer…”
Get more information